Press Releases

and/or
565 News Releases found
Ross Levine
Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at MSK.
MSK Awards and Appointments September 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Maria Jasin Awarded the 2025 Peral Meister Greengard...
Vinod Balachandran, MD and Research Associate Luis A. Rojas, PhD in the Balachandran Lab.
Memorial Sloan Kettering Cancer Center (MSK), one of the world’s leading institutions for cancer treatment, research, and education, and Quantoom Biosciences, a full-stack RNA technology partner have executed a non-exclusive research license and supply agreement to support the development of personalized cancer therapies using Quantoom’s proprietary lipid nanoparticle (LNP) formulation technology, Ncapsulate® QCX-002.
MSK Awards and Appointments
MSK Awards and Appointments August 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Matthew Bott Joins the Lung Cancer Research Fo...
Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first two quarters of 2025:
MSK Awards and Appointments July 2025
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:MSK Ranked the Best Cancer Center in the Northeast a...
Memorial Sloan Kettering Cancer Center Ranked as the Best Cancer Center in the Northeast, Second in the Nation, and First for Urology Care by U.S. News & World Report
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the best cancer center in the Northeast, the number two hospital for cancer care in the nation, and the number one hospital nationally for urology care by U.S. News & World Report in its annual Best Hospitals listing.
MSK patients will remain in-network to continue receiving world-class cancer care.
Awards and Appointments
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Brendan Camellato Named a 2025 Jane Coffin Chi...
William F. Pirl
Memorial Sloan Kettering Cancer Center (MSK) has named William F. Pirl, MD, MPH, as the new Chair of the Psychiatry & Behavioral Sciences Department. Dr. Pirl is a nationally and internationally recognized expert and leader in psycho-oncology. He is no stranger to MSK; he completed his fellowship in psycho-oncology at the institution twenty-five years ago.